New

Active Hemostatic Agents Market

2021

Active Hemostatic Agents Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Product Type (thrombin based hemostats, surgical sealants, combination products); End User (hospitals, ambulatory surgical centers, specialty clinics)

| Report Code: TIPRE00011954 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Active Hemostatic Agents Market 2028 By Product Type, End User | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Hemostatic agents are medical devices that are utilized to control bleeding during surgical procedures. Also, advancements in hemostasis technology have led to the development of a wide range of products that have enabled clinicians to provide proper emergency assistance to patients. Hemostatic products include thrombin sealants, fibrin glue, bovine serum/albumin/glutaraldehyde, gelatin matrix, microfibrillar collagen matrix, and oxidized regenerated cellulose. However, active hemostatic agents act physiologically by countering with blood coagulation cascade and lead to faster hemostasis.

MARKET DYNAMICS

The active hemostatic agents market is driving due to an increase in global trauma and accident cases. However, strict but inconsistent regulatory policies across the world are creating apprehensive environment among the market players, thereby restraining market growth of active hemostatic agents market. Moreover, the patient pool with different chronic diseases is also growing rapidly across the world.

MARKET SCOPE

The "Active Hemostatic Agents Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of active hemostatic agents market with detailed market segmentation by product type and end user. The active hemostatic agents market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in active hemostatic agents market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The active hemostatic agents market is segmented on the basis of product type and end user. Based on product type, the market is segmented as thrombin-based hemostats, surgical sealants, combination products. On the basis of end user, the market is categorized as hospitals, ambulatory surgical centers, and specialty clinics.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the active hemostatic agents market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The active hemostatic agents market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting active hemostatic agents market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the active hemostatic agents market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the active hemostatic agents market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from active hemostatic agents market are anticipated to have lucrative growth opportunities in the future with the rising demand for active hemostatic agents in the global market. Below mentioned is the list of few companies engaged in the active hemostatic agents market.

The report also includes the profiles of key players in active hemostatic agents market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Baxter International Inc.
  •   CryoLife, Inc.
  •   Ethicon Inc. (part of Johnson & Johnson Company)
  •   Integra Life Sciences Corporation
  •   Medtronic Plc.
  •   Pfizer Inc.


The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Active Hemostatic Agents Market - By Product Type
1.3.2 Active Hemostatic Agents Market - By End User
1.3.3 Active Hemostatic Agents Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ACTIVE HEMOSTATIC AGENTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ACTIVE HEMOSTATIC AGENTS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ACTIVE HEMOSTATIC AGENTS MARKET - GLOBAL MARKET ANALYSIS
6.1. ACTIVE HEMOSTATIC AGENTS - GLOBAL MARKET OVERVIEW
6.2. ACTIVE HEMOSTATIC AGENTS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ACTIVE HEMOSTATIC AGENTS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. THROMBIN BASED HEMOSTATS
7.3.1. Overview
7.3.2. thrombin based hemostats Market Forecast and Analysis
7.4. SURGICAL SEALANTS
7.4.1. Overview
7.4.2. surgical sealants Market Forecast and Analysis
7.5. COMBINATION PRODUCTS
7.5.1. Overview
7.5.2. combination products Market Forecast and Analysis
8. ACTIVE HEMOSTATIC AGENTS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. hospitals Market Forecast and Analysis
8.4. AMBULATORY SURGICAL CENTERS
8.4.1. Overview
8.4.2. ambulatory surgical centers Market Forecast and Analysis
8.5. SPECIALTY CLINICS
8.5.1. Overview
8.5.2. specialty clinics Market Forecast and Analysis
9. ACTIVE HEMOSTATIC AGENTS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Active Hemostatic Agents Market Overview
9.1.2 North America Active Hemostatic Agents Market Forecasts and Analysis
9.1.3 North America Active Hemostatic Agents Market Forecasts and Analysis - By Product Type
9.1.4 North America Active Hemostatic Agents Market Forecasts and Analysis - By End User
9.1.5 North America Active Hemostatic Agents Market Forecasts and Analysis - By Countries
9.1.5.1 United States Active Hemostatic Agents Market
9.1.5.1.1 United States Active Hemostatic Agents Market by Product Type
9.1.5.1.2 United States Active Hemostatic Agents Market by End User
9.1.5.2 Canada Active Hemostatic Agents Market
9.1.5.2.1 Canada Active Hemostatic Agents Market by Product Type
9.1.5.2.2 Canada Active Hemostatic Agents Market by End User
9.1.5.3 Mexico Active Hemostatic Agents Market
9.1.5.3.1 Mexico Active Hemostatic Agents Market by Product Type
9.1.5.3.2 Mexico Active Hemostatic Agents Market by End User
9.2. EUROPE
9.2.1 Europe Active Hemostatic Agents Market Overview
9.2.2 Europe Active Hemostatic Agents Market Forecasts and Analysis
9.2.3 Europe Active Hemostatic Agents Market Forecasts and Analysis - By Product Type
9.2.4 Europe Active Hemostatic Agents Market Forecasts and Analysis - By End User
9.2.5 Europe Active Hemostatic Agents Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Active Hemostatic Agents Market
9.2.5.1.1 Germany Active Hemostatic Agents Market by Product Type
9.2.5.1.2 Germany Active Hemostatic Agents Market by End User
9.2.5.2 France Active Hemostatic Agents Market
9.2.5.2.1 France Active Hemostatic Agents Market by Product Type
9.2.5.2.2 France Active Hemostatic Agents Market by End User
9.2.5.3 Italy Active Hemostatic Agents Market
9.2.5.3.1 Italy Active Hemostatic Agents Market by Product Type
9.2.5.3.2 Italy Active Hemostatic Agents Market by End User
9.2.5.4 Spain Active Hemostatic Agents Market
9.2.5.4.1 Spain Active Hemostatic Agents Market by Product Type
9.2.5.4.2 Spain Active Hemostatic Agents Market by End User
9.2.5.5 United Kingdom Active Hemostatic Agents Market
9.2.5.5.1 United Kingdom Active Hemostatic Agents Market by Product Type
9.2.5.5.2 United Kingdom Active Hemostatic Agents Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Active Hemostatic Agents Market Overview
9.3.2 Asia-Pacific Active Hemostatic Agents Market Forecasts and Analysis
9.3.3 Asia-Pacific Active Hemostatic Agents Market Forecasts and Analysis - By Product Type
9.3.4 Asia-Pacific Active Hemostatic Agents Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Active Hemostatic Agents Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Active Hemostatic Agents Market
9.3.5.1.1 Australia Active Hemostatic Agents Market by Product Type
9.3.5.1.2 Australia Active Hemostatic Agents Market by End User
9.3.5.2 China Active Hemostatic Agents Market
9.3.5.2.1 China Active Hemostatic Agents Market by Product Type
9.3.5.2.2 China Active Hemostatic Agents Market by End User
9.3.5.3 India Active Hemostatic Agents Market
9.3.5.3.1 India Active Hemostatic Agents Market by Product Type
9.3.5.3.2 India Active Hemostatic Agents Market by End User
9.3.5.4 Japan Active Hemostatic Agents Market
9.3.5.4.1 Japan Active Hemostatic Agents Market by Product Type
9.3.5.4.2 Japan Active Hemostatic Agents Market by End User
9.3.5.5 South Korea Active Hemostatic Agents Market
9.3.5.5.1 South Korea Active Hemostatic Agents Market by Product Type
9.3.5.5.2 South Korea Active Hemostatic Agents Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Active Hemostatic Agents Market Overview
9.4.2 Middle East and Africa Active Hemostatic Agents Market Forecasts and Analysis
9.4.3 Middle East and Africa Active Hemostatic Agents Market Forecasts and Analysis - By Product Type
9.4.4 Middle East and Africa Active Hemostatic Agents Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Active Hemostatic Agents Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Active Hemostatic Agents Market
9.4.5.1.1 South Africa Active Hemostatic Agents Market by Product Type
9.4.5.1.2 South Africa Active Hemostatic Agents Market by End User
9.4.5.2 Saudi Arabia Active Hemostatic Agents Market
9.4.5.2.1 Saudi Arabia Active Hemostatic Agents Market by Product Type
9.4.5.2.2 Saudi Arabia Active Hemostatic Agents Market by End User
9.4.5.3 U.A.E Active Hemostatic Agents Market
9.4.5.3.1 U.A.E Active Hemostatic Agents Market by Product Type
9.4.5.3.2 U.A.E Active Hemostatic Agents Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Active Hemostatic Agents Market Overview
9.5.2 South and Central America Active Hemostatic Agents Market Forecasts and Analysis
9.5.3 South and Central America Active Hemostatic Agents Market Forecasts and Analysis - By Product Type
9.5.4 South and Central America Active Hemostatic Agents Market Forecasts and Analysis - By End User
9.5.5 South and Central America Active Hemostatic Agents Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Active Hemostatic Agents Market
9.5.5.1.1 Brazil Active Hemostatic Agents Market by Product Type
9.5.5.1.2 Brazil Active Hemostatic Agents Market by End User
9.5.5.2 Argentina Active Hemostatic Agents Market
9.5.5.2.1 Argentina Active Hemostatic Agents Market by Product Type
9.5.5.2.2 Argentina Active Hemostatic Agents Market by End User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ACTIVE HEMOSTATIC AGENTS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ACTIVE HEMOSTATIC AGENTS MARKET, KEY COMPANY PROFILES
12.1. BAXTER INTERNATIONAL INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. CRYOLIFE, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ETHICON INC. (PART OF JOHNSON AND JOHNSON COMPANY)
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. INTEGRA LIFE SCIENCES CORPORATION
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MEDTRONIC PLC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. PFIZER INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Baxter International Inc.
2. CryoLife, Inc.
3. Ethicon Inc. (part of Johnson & Johnson Company)
4. Integra Life Sciences Corporation
5. Medtronic Plc.
6. Pfizer Inc.
TIPRE00011954
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.